Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Fentanyl-Responsive Microneedle Patch for Harm Reduction.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Medial prefrontal cortical neurotransmitters reactive to relapse-promoting and relapse-suppressing cues in male rats trained to self-administer cocaine or alcohol.

Addiction neuroscience·2026
Same author

Brain injury contributes to dopaminergic neurodegeneration, Lewy body pathology, and Parkinsonism preclinically with outcomes altered by T cell modulation.

bioRxiv : the preprint server for biology·2025
Same author

Alcohol use disorder-associated pain: clinical and preclinical evidence.

Alcohol (Fayetteville, N.Y.)·2025
Same author

12/15-lipoxygenases mediate toll-like receptor 4-dependent nociplastic pain hypersensitivity in female mice.

Pain·2025
Same author

The Predictive Value of Plasma Bioactive Lipids on Craving in Human Volunteers With Alcohol Use Disorder.

Biological psychiatry global open science·2024

Related Experiment Video

Updated: Jun 11, 2026

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.

Matthew W Buczynski1, Loren H Parsons

  • 1Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA.

British Journal of Pharmacology
|July 2, 2010
PubMed
Summary

Accurately quantifying brain endocannabinoids (lipid signaling molecules) is crucial for understanding neurological disorders. This review critically examines methods like lipid extraction and microdialysis, highlighting challenges in interpreting brain endocannabinoid levels.

More Related Videos

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Related Experiment Videos

Last Updated: Jun 11, 2026

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Area of Science:

  • Neuroscience
  • Neurochemistry
  • Analytical Chemistry

Background:

  • Endocannabinoids are vital signaling lipids involved in numerous neurophysiological processes, including neural development, neuroimmunity, synaptic plasticity, pain, and reward.
  • Dysregulation of endocannabinoid signaling is implicated in various neuropathologies, increasing the need for precise quantification of these molecules in brain tissue.
  • Existing quantification methods, such as lipid extraction and in vivo microdialysis, yield variable results, prompting debate on physiological endocannabinoid concentrations.

Purpose of the Study:

  • To critically review factors influencing the quantification of endocannabinoid content in brain tissue.
  • To compare and contrast lipid extraction from bulk tissue with in vivo microdialysis for endocannabinoid sampling.
  • To identify methodological issues and provide guidance for appropriate data interpretation.

Main Methods:

  • Review of established lipid extraction techniques (solvent-based extraction, solid-phase extraction) for brain tissue.
  • Analysis of in vivo microdialysis methods for sampling endocannabinoids from the brain's interstitial space.
  • Discussion of analytical approaches, extraction/purification challenges, post-mortem changes, and microdialysis probe effects.

Main Results:

  • Significant variability exists in reported endocannabinoid concentrations across different brain regions and studies.
  • Methodological choices profoundly impact measured endocannabinoid levels, affecting physiological range estimations.
  • Factors such as post-mortem degradation, cellular responses to probes, and extracellular sampling limitations introduce potential biases.

Conclusions:

  • Both lipid extraction and microdialysis have distinct benefits and limitations for quantifying brain endocannabinoids.
  • Careful consideration of methodological factors is essential for accurate interpretation of endocannabinoid data.
  • Further refinement of analytical techniques is needed to establish reliable physiological ranges and understand endocannabinoid roles in health and disease.